You're absolutely right. Now its definitive and timeline has just focused further. We are 'literally' a month away. 2nd/3rd week of Jan will BE INTERESTING.
Think about the fact that enrollment has sped up once we placed a focus on the trial at the hospitals completing the assessment. It would seem with the enrollment filling up quickly the hospitals in the trial are seeing excellent results in some patients. Otherwise we would still be floundering, trying to get buy in. I believe this is a really good sign. I actually ran a double blind study determining the effects of a couple drugs on senility early in my career. Obviously people did not die in this study so it was hard to determine who got what, the drugs or placebo, but in this study the outcomes are more apparent.
News 
Market Data 
Discover 
AI
